Generalized integral transform solution for hydrodynamically developing non-Newtonian flows in circular tubes

ABSTRACT: The Generalized Integral Transform Technique (GITT) is applied to the solution of the momentum equations in a hydrodynamically developing laminar flow of a non-Newtonian power-law fluid inside a circular duct. A primitive variables formulation is adopted in order to avoid the singularity of the auxiliary eigenvalue problem in terms of Bessel functions at the centerline of the duct when the GITT approach is applied. Results for the velocity field and friction factor-Reynolds number product are computed for different power-law indices, which are tabulated and graphically presented as functions of the dimensionless coordinates. Critical comparisons with previous results in the literature are also performed, in order to validate the numerical codes developed in the present work and to demonstrate the consistency of the final results.

Effect of andiroba oil on periodontitis in Wistar rats

PURPOSE: To evaluate the effects of andiroba oil on the periodontitis in rats. METHODS: The periodontitis was induced by the placement of cotton ligatures around the cervix of the second upper molars on fifteen rats, and waiting fifty days. The animals were randomly distributed into three groups: saline group, andiroba oil group and meloxican group, differentiated by substance used in the treatment of periodontitis. The groups received the respective substance by gavage for seven days, after the periodontitis induced. It was analyzed the score of inflammatory cells and the measurement from the cemento-enamel junction to the bone crest. RESULTS: The andiroba oil group (p=0.008) and meloxican group (p=0.0347) show a less score of inflammatory cells than saline group, however there weren't difference between them (p=0.2754). Regarding the analysis of measurement from the cemento-enamel junction to the bone crest, there was no difference between groups studied (p=0.3451). CONCLUSION: Andiroba oil decreased the quantity of inflammatory cells, however, it didn't have an effect on the measurement of alveolar bone loss, like the treatment with Meloxican®.